Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11720323rdf:typepubmed:Citationlld:pubmed
pubmed-article:11720323lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11720323lifeskim:mentionsumls-concept:C0010346lld:lifeskim
pubmed-article:11720323lifeskim:mentionsumls-concept:C0162836lld:lifeskim
pubmed-article:11720323lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:11720323lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:11720323lifeskim:mentionsumls-concept:C0666743lld:lifeskim
pubmed-article:11720323lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:11720323lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:11720323pubmed:issue4lld:pubmed
pubmed-article:11720323pubmed:dateCreated2001-11-26lld:pubmed
pubmed-article:11720323pubmed:abstractTextCutaneous manifestations occur frequently in inflammatory bowel disease. The association between hidradenitis suppurativa (HS) and Crohn's disease (CD) has been reported. We present a new case supporting this association. A dramatic improvement after treatment with infliximab was achieved for both refractory fistulizing CD and axillary HS.lld:pubmed
pubmed-article:11720323pubmed:languageenglld:pubmed
pubmed-article:11720323pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11720323pubmed:citationSubsetIMlld:pubmed
pubmed-article:11720323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11720323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11720323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11720323pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11720323pubmed:statusMEDLINElld:pubmed
pubmed-article:11720323pubmed:monthNovlld:pubmed
pubmed-article:11720323pubmed:issn1078-0998lld:pubmed
pubmed-article:11720323pubmed:authorpubmed-author:PonceJJlld:pubmed
pubmed-article:11720323pubmed:authorpubmed-author:MartínezFFlld:pubmed
pubmed-article:11720323pubmed:authorpubmed-author:BenllochSSlld:pubmed
pubmed-article:11720323pubmed:authorpubmed-author:JiS JSJlld:pubmed
pubmed-article:11720323pubmed:issnTypePrintlld:pubmed
pubmed-article:11720323pubmed:volume7lld:pubmed
pubmed-article:11720323pubmed:ownerNLMlld:pubmed
pubmed-article:11720323pubmed:authorsCompleteYlld:pubmed
pubmed-article:11720323pubmed:pagination323-6lld:pubmed
pubmed-article:11720323pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:meshHeadingpubmed-meshheading:11720323...lld:pubmed
pubmed-article:11720323pubmed:year2001lld:pubmed
pubmed-article:11720323pubmed:articleTitleHidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.lld:pubmed
pubmed-article:11720323pubmed:affiliationDepartment of Gastroenterology and Hepatology, Hospital La Fe, Valencia, Spain. Fernandomarju@hotmail.comlld:pubmed
pubmed-article:11720323pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11720323pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11720323lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11720323lld:pubmed